The Association of Community Cancer Centers (ACCC) has established the ACCC Community Oncology Research Institute (ACORI) to build on its existing mission to close the gap in cancer research through optimal oncology partnerships. As part of this mission, ACCC hosted the ACORI Call to Action Summit, a two-day virtual event that explored practical solutions to strengthen and diversify oncology clinical trials in communities across the country.
The Summit's interactive discussions focused around:
We look forward to continuing these conversations and taking action that will tie directly into ACORI's three domains of equity, capacity building, and research diffusion. If you were not able to join us live, the ACORI Summit is now available to view on-demand.
For more information on this project, please contact the ACCC Provider Education department.
The ACORI Call to Action Summit’s Executive Summary was developed as an overview of the action items co-developed by the Summit participants for ACCC and oncology programs and practices, as well as other stakeholders. These action items are intended to serve as foundational resources in support of the ACORI stakeholders in their work to improve equity and inclusion in research and diversify clinical trials.
Learn more about the Summit, the developed action items, and more in this comprehensive Executive Summary.
This project is supported by AbbVie, Amgen, AstraZeneca, Eisai, Genentech, Merck and Sanofi.
